The role of soluble epoxide hydrolase and its inhibitors in depression
Open Access
- 9 August 2021
- journal article
- review article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 16, 100325
Abstract
No abstract availableKeywords
Funding Information
- King's College London
- South London and Maudsley NHS Foundation Trust
- Medical Research Council (MR/J002739/1and MR/N029488/1, MR/L014815/1)
- National Institute for Health Research
- European Commission
This publication has 61 references indexed in Scilit:
- Coverage of Blood Vessels by Astrocytic Endfeet Is Reduced in Major Depressive DisorderBiological Psychiatry, 2013
- Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in DepressionThe Journal of Clinical Psychiatry, 2011
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorderJournal of Affective Disorders, 2010
- Antidepressants increase neural progenitor cells in the human hippocampusNeuropsychopharmacology, 2009
- Distribution and Expression of Soluble Epoxide Hydrolase in Human BrainJournal of Histochemistry & Cytochemistry, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Requirement of Hippocampal Neurogenesis for the Behavioral Effects of AntidepressantsScience, 2003
- The Biochemistry of n-3 Polyunsaturated Fatty AcidsJournal of Biological Chemistry, 2002
- Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessmentInternational Journal of Psychophysiology, 1989